Login

Ekso Bionics Holdings, Inc EKSO CEO Jack Peurach on 2019 Results 00:00:00

Share On Facebook Share On Twitter

Ekso Bionics Holdings, Inc EKSO CEO Jack Peurach on 2019 Results

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Navigating Private Capital Markets: Insights from Jean Phillippe Keravec at IPEM 2020
00:10:00
5E Advanced Materials Aims for Global Leadership in Boron and Lithium Supply
00:10:00
ALWAYS BE THE TRACK IS THE RIGHT TALENT FOR LASTING SUCCESS|Scott Dinhofer, CEO,Weatherly Financial GroupLLC
00:00:00
4D Pharma hopes to expand drug success to other areas - Duncan Peyton, CEO, 4D Pharma
00:10:00
Fermentalg’s Philippe Lavielle on Collaborating with iTak Strategies for Growth | Philippe Lavielle, CEO , FERMENTALG SA.
00:10:00
Western Exploration Launches 2024 Drill Program at Gravel Creek with Promising High-Grade Gold Results
00:10:00
Victor Orban's Path to Power: From Dissident to Leader|Thibaud Gibelin,Professor,University of Augsburg
00:10:00
Canadas Zinc Corp: Advancing Zinc-Lead-Silver Projects in British Columbia
00:10:00
focuses on early stage companies in consumer and enterprise software|Saam Motamedi,General Partner,Greylock
00:10:00
We believe the key to treating neurodegenerative disease is to intervene early|David Kalergis,CEO,Diffusion Pharmaceuticals Inc
00:10:00
The Impact of Comprehensive Wealth Management | David John Marotta, President , Marotta Wealth Management Inc.
00:10:00
Rochester Mine Expansion Set to Transform Coeur Mining's Free Cash Flow | Mitchell J. Krebs - President and CEO of Coeur Mining Inc

© 2017 - Neuhu+